XML 46 R35.htm IDEA: XBRL DOCUMENT v3.19.2
Revenue (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenue          
Revenue   $ 525 $ 847 $ 2,228 $ 8,398
Collaboration revenue          
Revenue          
Revenue       1,000 6,500
Collaboration revenue - upfront payment | License Agreement | Sinovant Sciences, LTD          
Revenue          
Revenue accounted for under Topic 606 $ 5,000       5,000
Collaboration revenue - upfront payment | License Agreement | Sunovion Pharmaceutics Canada, Inc.          
Revenue          
Revenue not accounted for under Topic 606       1,000  
Collaboration revenue - Variable consideration | Clinical trial application submission          
Revenue          
Revenue accounted for under Topic 606       1,500  
Collaboration revenue - Variable consideration | License Agreement | Clinical trial application submission | Sinovant Sciences, LTD          
Revenue          
Revenue accounted for under Topic 606         1,500
Research premium          
Revenue          
Revenue   351 709 744 1,479
Government grants          
Revenue          
Revenue   $ 174 $ 138 $ 484 $ 419